145 related articles for article (PubMed ID: 1942933)
1. [Testicular function after OPA/COMP chemotherapy without procarbazine in boys with Hodgkin's disease. Results in 25 patients of the DAL-HD-85 study].
Hassel JU; Brämswig JH; Schlegel W; Schellong G
Klin Padiatr; 1991; 203(4):268-72. PubMed ID: 1942933
[TBL] [Abstract][Full Text] [Related]
2. The effects of etoposide on testicular function in boys treated for Hodgkin's disease.
Gerres L; Brämswig JH; Schlegel W; Jürgens H; Schellong G
Cancer; 1998 Nov; 83(10):2217-22. PubMed ID: 9827728
[TBL] [Abstract][Full Text] [Related]
3. The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence.
Brämswig JH; Heimes U; Heiermann E; Schlegel W; Nieschlag E; Schellong G
Cancer; 1990 Mar; 65(6):1298-302. PubMed ID: 2106384
[TBL] [Abstract][Full Text] [Related]
4. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Bokemeyer C; Schmoll HJ; van Rhee J; Kuczyk M; Schuppert F; Poliwoda H
Ann Hematol; 1994 Mar; 68(3):105-10. PubMed ID: 8167175
[TBL] [Abstract][Full Text] [Related]
5. [Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
Soriano Guillén L; Muñoz Calvo MT; Pozo Román J; Contra Gómez T; Buño Soto M; Argente Oliver J
An Esp Pediatr; 2000 Oct; 53(4):318-23. PubMed ID: 11083980
[TBL] [Abstract][Full Text] [Related]
6. Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook.
Dörffel W; Lüders H; Rühl U; Albrecht M; Marciniak H; Parwaresch R; Pötter R; Schellong G; Schwarze EW; Wickmann L
Klin Padiatr; 2003; 215(3):139-45. PubMed ID: 12838937
[TBL] [Abstract][Full Text] [Related]
7. [Significance of procarbazine in the chemotherapy of Hodgkin's disease--a report of the Cooperative Therapy Study DAL-HD-85].
Schellong G; Hörnig I; Brämswig J; Bökkerink JP; Steinhoff A; Ludwig R; Niethammer D; Reiter A; von Lengerke HJ; Heinecke H
Klin Padiatr; 1988; 200(3):205-13. PubMed ID: 3062257
[TBL] [Abstract][Full Text] [Related]
8. Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
Schellong G; Riepenhausen M; Creutzig U; Ritter J; Harbott J; Mann G; Gadner H
J Clin Oncol; 1997 Jun; 15(6):2247-53. PubMed ID: 9196137
[TBL] [Abstract][Full Text] [Related]
9. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
[TBL] [Abstract][Full Text] [Related]
10. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
Giuseppe L; Attilio G; Edoardo DN; Loredana G; Cristina L; Vincenzo L
Hematology; 2007 Apr; 12(2):141-7. PubMed ID: 17454195
[TBL] [Abstract][Full Text] [Related]
11. High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group.
Schellong G; Pötter R; Brämswig J; Wagner W; Prott FJ; Dörffel W; Körholz D; Mann G; Rath B; Reiter A; Weissbach G; Riepenhausen M; Thiemann M; Schwarze EW
J Clin Oncol; 1999 Dec; 17(12):3736-44. PubMed ID: 10577845
[TBL] [Abstract][Full Text] [Related]
12. Gonadal function in young patients successfully treated for Hodgkin disease.
Papadakis V; Vlachopapadopoulou E; Van Syckle K; Ganshaw L; Kalmanti M; Tan C; Sklar C
Med Pediatr Oncol; 1999 May; 32(5):366-72. PubMed ID: 10219339
[TBL] [Abstract][Full Text] [Related]
13. Testicular dysfunction after cyclophosphamide-vincristine-procarbazine-prednisolone chemotherapy for advanced Hodgkin's disease. A long-term follow-up study.
Charak BS; Gupta R; Mandrekar P; Sheth NA; Banavali SD; Saikia TK; Gopal R; Dinshaw KA; Advani SH
Cancer; 1990 May; 65(9):1903-6. PubMed ID: 2115396
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
Eichenauer DA; Plütschow A; Kreissl S; Sökler M; Hellmuth JC; Meissner J; Mathas S; Topp MS; Behringer K; Klapper W; Kuhnert G; Dietlein M; Kobe C; Fuchs M; Diehl V; Engert A; Borchmann P
Lancet Oncol; 2017 Dec; 18(12):1680-1687. PubMed ID: 29133014
[TBL] [Abstract][Full Text] [Related]
15. Gonadal function in prepubertal boys following treatment for Hodgkin's disease.
Dhabhar BN; Malhotra H; Joseph R; Garde S; Bhasin S; Sheth A; Advani SH
Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):306-10. PubMed ID: 8328644
[TBL] [Abstract][Full Text] [Related]
16. Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease.
Heikens J; Behrendt H; Adriaanse R; Berghout A
Cancer; 1996 Nov; 78(9):2020-4. PubMed ID: 8909325
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin's disease in children: combined modality treatment for stages IA, IB, and IIA. Results in 356 patients of the German/Austrian Pediatric Study Group.
Schellong G; Brämswig JH; Hörnig-Franz I; Schwarze EW; Pötter R; Wannenmacher M
Ann Oncol; 1994; 5 Suppl 2():113-5. PubMed ID: 8204510
[TBL] [Abstract][Full Text] [Related]
18. Treatment of children and adolescents with Hodgkin's disease: the experience of the German-Austrian Paediatric Study Group.
Schellong G
Baillieres Clin Haematol; 1996 Sep; 9(3):619-34. PubMed ID: 8922249
[TBL] [Abstract][Full Text] [Related]
19. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience.
Al-Tonbary Y; Sarhan MM; El-Ashry RA; Salama E; Sedki M; Fouda A
Leuk Lymphoma; 2010 Apr; 51(4):656-63. PubMed ID: 20218813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
